Research Study for the Investigational Use of XEOMIN to treat Blepharospasm (an FDA approved alternative to BOTOX)

Blepharospasm, a condition of uncontrolled blinking of the eyelids, had been traditionally treated with BOTOX.  There is now a new product called XEOMIN that is also FDA approved for treatment of this condition.  Our experience is that XEOMIN is an excellent alternative to BOTOX.  We are now conducting an observational research study that will help us to further determine patient satisfaction with this product.  Patients who are candidates for this procedure will be invited to enter the study and will be compensated for completing the questionnaires. 

Have You Been Using LATISSE Since Before April 2010 ? 

If so, you might be eligible to take part in an observational study. 

This study is for patients who began using LATISSE prior to April, 2010 and continued its use for a period of at least 12 months.  Eligible participants will be asked to complete a questionnaire and provide information about their usage of the product.  Participants will be compensated $50 for their time.

If you are eligible for either of these studies, please call our office at 212.727.3717